Dis­counts for weight loss drugs are es­ti­mat­ed at more than half, fu­el­ing ques­tions about price, PBMs and cov­er­age

Pop­u­lar weight loss drugs are like­ly be­ing dis­count­ed by half or more from their list prices, ac­cord­ing to a new study, a gap that’s ex­pect­ed to height­en ten­sions about pa­tients’ ac­cess to the prod­ucts and out-of-pock­et spend­ing.

While wide gaps be­tween a drug’s list price and what’s ac­tu­al­ly paid are com­mon, the GLP-1 drugs are unique. They’ve be­come one of the fastest-sell­ing cat­e­gories of all time, and many peo­ple are pay­ing out-of-pock­et at the much high­er list prices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER